Savvy Updates, 5/28/24: CamDiab Hybrid Closed Loop Approved, FDA Rejects Icodec, Ozempic Protects Kidneys, GLP-1 OK for Surgery, Physician Compensation Report 2024, Novo Nordisk Fires, Think Like a Pancreas: Is there a conspiracy?, Air Protein Solein, FIX Prior Authorizations
FDA approves hybrid closed-loop insulin delivery app from CamDiab by Sean Whooley for DrugDelieveryBusiness.com, 24 May 2024. CamDiab announced today that the FDA granted authorization for its CamAPS FX advanced adaptive closed-loop artificial pancreas app. CamAPS FX,...
Savvy Updates 5/20/24: Twiist Insulin Pump, FDA Alerts on Chinese Syringe Imports, Playing Sports Lowers Insulin Resistance, Insulin Sensitizers, Dr. Rayhan Lal on Automated Insulin Delivery Systems, ADA Lists Best Hospitals for T1Ds (ONLY 17 in the US!), CGMs & Insulin Pumps for T2D Market, Black Basta Cyberattacks on Healthcare Systems, Prior Auths Need to be Fixed
Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin by Stacey Simms for Diabetes-Connections.com, 16 April 2024. This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that...
Savvy Updates, 5/13/2024: Tandem t:slim X2 App Recall, Novo Nordisk Drops Prices on GLP-1s, Xeris & Beta Bionics, Nanotech for Oral Insulin Delivery, Exocrine Pancreatic Insufficiency & T1D, Know Labs NI CGM & Machine Learning, Ascension Hacked, Stewart Health Files Chapter 11, On the Lighter Side – Parrots Prefer Live Video Calls!
FDA Warns on (Tandem) Insulin Pump Problem by Kristen Monaco for MedPageToday.com, 8 May 2024. Mobile app glitch may cause t:slim X2 insulin pump battery to drain sooner than expected. A mobile app used with an insulin pump that led to 224 injuries was recalled...
Savvy Updates, 5/6/24: Eversense Authorized for Pump Integration, Walmart Health Shuts Down, Lilly Scales Up GLP-1 Production, Novo Prices Drop on GLP-1s, CVS Earnings Slashed, Neotame Sweetener Damages Gut, FTC Polices FDA’s Orange Book “Improper Listings”
Fully-implantable CGM receives FDA authorization for integration with insulin pumps by Jill Rollet for Healio.com/endocrinology, 30 April 2024. The Eversense E3 CGM (Senseonics Holdings and Ascensia Diabetes Care) received authorization to be marketed as an integrated...
Savvy Updates, 4/29/24: Cadisegliatin Regulates BG in Liver, Diabetes Driving Pal App, Female Physicians Result in Better Health Outcomes, UHC Data Breach “Substantial”, Pancreas Anatomy Image, Little Sleep Risky for T1D Teens, Vertex/TreeFrog Collab, Mounjaro/Zepbound Shortages, Ozempic in Denmark, Roasted Green Tea (houjicha)
Introducing Cadisegliatin, a New Drug in the Type 1 Diabetes Pipeline by Ross Wollen for DiabetesDaily.com, 26 April 2024. Cadisegliatin, an investigative therapy currently entering phase 3 trials, could be the next important drug, after insulin, indicated for Type 1...
More Diabetes Blogs